Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer.

MLA

Kaira, Kyoichi, et al. “Pooled Analysis of the Reports of Erlotinib after Failure of Gefitinib for Non-Small Cell Lung Cancer.” Lung Cancer (Amsterdam, Netherlands), vol. 68, no. 1, Apr. 2010, pp. 99–104. EBSCOhost, https://doi.org/10.1016/j.lungcan.2009.05.006.

APA

Kaira, K., Naito, T., Takahashi, T., Ayabe, E., Shimoyama, R., Kaira, R., Ono, A., Igawa, S., Shukuya, T., Murakami, H., Tsuya, A., Nakamura, Y., Endo, M., & Yamamoto, N. (2010). Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 68(1), 99–104. https://doi.org/10.1016/j.lungcan.2009.05.006

Chicago

Kaira, Kyoichi, Tateaki Naito, Toshiaki Takahashi, Eriko Ayabe, Rai Shimoyama, Rieko Kaira, Akira Ono, et al. 2010. “Pooled Analysis of the Reports of Erlotinib after Failure of Gefitinib for Non-Small Cell Lung Cancer.” Lung Cancer (Amsterdam, Netherlands) 68 (1): 99–104. doi:10.1016/j.lungcan.2009.05.006.